March 31, 2026

Equal Pay in Ophthalmology? Not Yet

A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks

Conexiant

March 24, 2026

Artificial Tears Reduce Dryness Symptoms in 1-Month Study

Prospective multicenter study without a control group shows symptom scores reduced by more than half after 4 weeks of treatment

Conexiant

March 23, 2026

FDA Approves TECNIS PureSee IOL for Cataract Surgery

First FDA-approved extended depth of focus (EDOF) IOL maintaining contrast sensitivity comparable to an aspheric monofocal IOL

The Ophthalmologist

March 16, 2026

Scaling Vision Innovation

Rob Scott, Vice President of Intraocular Devices R&D, Alcon

The Ophthalmologist

March 12, 2026

Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

Conexiant

March 11, 2026

Women Prefer Contact Lens Under-Correction

Clinic-based study suggests sex differences in preferred contact lens under-correction during presbyopia management

Conexiant

June 01, 2025

Orthokeratology Today: Orthokeratology: What’s on the Horizon?

Discover the exciting future of ortho-k lenses and their potential for myopia control, hyperopia, and presbyopia correction. A comprehensive overview by Ashley Wallace-Tucker, OD.

Contact Lens Spectrum

January 01, 2026

Is This the New Norm?: Large Pupils and Visual Performance

Explore how pupil size impacts night vision and discover therapeutic strategies for improvement, as presented in a compelling clinical case.

Contact Lens Spectrum

March 02, 2026

Presbyopia Solutions for Patients With Retinal Disease

When prescribing spectacle lenses, one of the most impactful things we can do is ask: “What are your visual goals?” or more simply, “What are you struggling to see clearly?”

Optometric Management

January 01, 2026

New Medications for Dry Eye and Presbyopia

Topical miotics are approved for use in all adults with presbyopia, including post-LASIK patients and pseudophakes, and acoltremon is a treatment option for multiple dry eye subtypes, either as primary therapy or adjunctive treatment.

Optometric Management